We've updated our software system. Your login credentials remain the same, but you'll need to reconnect your patient profile after signing in. Thank you for your patience and understanding.
New Study Suggests No Major Adverse Outcomes With Early GLP-1 Exposure During Pregnancy
Researchers found no substantial increase in the risk of pregnancy loss, abnormal fetal growth, or major congenital malformations among pregnancies with first-trimester GLP-1 exposure. But they say more studies are needed.
Health News is provided as a service to Medical Center Pharmacy site users by HealthDay. Medical Center Pharmacy nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.